Baillie Gifford & Co’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Sell
218,430
-26,698
-11% -$7.08M 0.1% 131
2026
Q1
$26.9M Sell
245,128
-7,785
-3% -$1.11M 0.03% 171
2025
Q4
$42.1M Buy
252,913
+22,126
+10% +$3.7M 0.04% 158
2025
Q3
$45.2M Sell
230,787
-2,440
-1% -$401K 0.03% 158
2025
Q2
$21.1M Buy
+233,227
New +$18.4M 0.02% 186

Other funds holding ALAB

Baillie Gifford & Co's ALAB Position: Q2 2026 in Review

Baillie Gifford & Co reduced its Astera Labs (ALAB) stake by 11% in Q2 2026, selling an estimated $7.08M and leaving 218,430 shares worth $106M. The position accounts for 0.1% of the portfolio, ranked #131.

Baillie Gifford & Co first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Baillie Gifford & Co held 218,430 shares of Astera Labs worth $106M as of Q2 2026.
  • Baillie Gifford & Co sold 26,698 Astera Labs shares in Q2 2026, an estimated $7.08M.
  • Astera Labs made up 0.1% of Baillie Gifford & Co's portfolio in Q2 2026, its #131 holding.
  • Baillie Gifford & Co first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Baillie Gifford & Co's 13F filing for Q2 2026, filed 6 Aug 2026.